MedTrace Logo

Chondrofix Osteochondral Allograft Prospective Study

NCT01410136 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2014-08-11

No results posted yet for this study

Summary

The overall study objective is to evaluate Chondrofix Osteochondral Allograft ("Chondrofix") for the repair of osteochondral lesions in the knee. This includes, but is not limited to primary cartilage lesion repair and revision of failed prior cartilage repair treatments. The study hypothesis is that Chondrofix Allograft will provide pain relief and functional improvement as demonstrated by a comparative analysis of baseline clinical evaluations at 24 months of follow-up.

Conditions

  • Articular Cartilage Disorder
  • Degeneration; Articular Cartilage
  • Chronic Cartilage Injury
  • Acute Cartilage Injury
  • Defect of Articular Cartilage

Interventions

PROCEDURE

Chondrofix Osteochondral Allograft

Allogeneic, cylindrical, decellularized, osteochondral graft composed of hyaline cartilage and bone

Sponsors & Collaborators

  • Zimmer Orthobiologics, Inc.

    lead INDUSTRY

Principal Investigators

  • Nikesha N Harrington · Zimmer Orthobiologics, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01410136 on ClinicalTrials.gov